Pfizer Ltd has informed BSE that the Board of Directors of the Company at its meeting held on September 26, 2009, inter alia, has, subject to receipt of all requisite consents and approvals from statutory and regulatory authorities pursuant to the applicable provisions of the Companies Act, 1956, approved the Scheme of Amalgamation of Duchem Laboratories Ltd (wholly owned subsidiary of Pfizer Ltd) and Pfizer Ltd. The Scheme is proposed to be effective December 01, 2008. The Transferor Company being the wholly owned subsidiary of Pfizer Ltd, no consideration shall be payable to the Transferor Company or its shareholders pursuant to the Amalgamation and the shares held by Pfizer Ltd and its nominees in the Transferor Company shall stand cancelled. Pfizer Ltd has informed BSE that the Bombay High Court vide its Order dated February 26, 2010, has sanctioned the Scheme of Amalgamation of Duchem Laboratories Ltd., the unlisted wholly-owned subsidiary with Pfizer Ltd. A copy of the said Order is being filed with Registrar of Companies, Maharashtra, Mumbai. Further the Company noted that, the appointed date of the said Scheme of Amalgamation is December 01, 2008. (As Per BSE Announcement Website dated on 15.03.2010) Pfizer Ltd has informed BSE regarding the Outcome of Board meeting held on March 19, 2010 for the reconsideration of financial results on account of Court Approval to the Scheme of Amalgamation between Duchem Laboratories Ltd. (the unlisted wholly-owned subsidiary) with Pfizer Ltd. (As Per BSE Announcement Website dated on 22.03.2010)